The presented program is laid out as integrated Drug Substance, Particle Engineering and Drug Product services, enabling drug substance and drug product delivery in 40 weeks or less from the start of the project to the readiness, drug substance manufacturing to GMP drug product manufacturing. Drug product formulation design is guided using biorelevant screening tools to rapidly and predictively develop optimized formulations.
This presentation will include case studies to further discuss the services available through Lonza’s SimpliFiH® Solutions program and will provide a line of sight for post first-in-human milestones.
